Choong Ang Vaccine Laboratory operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Choong Ang Vaccine Laboratory with three other
companies in this sector in South Korea:
ISU Abxis Company Limited
sales of 19.05 billion Korean Won [US$17.84 million]
of which 98%
was Antibody Medicine),
(17.95 billion Korean Won [US$16.80 million]
of which 86%
was The clinical trial agent), and
Komipharm International Company Limited
(37.64 billion Korean Won [US$35.23 million]
of which 100%
was Animal Pharmaceutical).
During the year ended December of 2016, sales at
Choong Ang Vaccine Laboratory were 37.90 billion Korean Won (US$35.47 million).
increase of 9.5%
versus 2015, when the company's sales were 34.60 billion Korean Won.
This was the fifth consecutive year of sales increases at Choong Ang Vaccine Laboratory
(and since 2011, sales have increased a total of 143%).